Squarepoint’s Checkpoint Therapeutics CKPT Stock Holding History

Squarepoint’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-471,385	Closed	-$1.9M	–	4552
2025 Q1	$1.9M	Buy	471,385 +399,447	+555%	+$1.33M	﹤0.01%	2133
2024 Q4	$230K	Buy	+71,938	New	+$244K	﹤0.01%	4361
2024 Q1	–	Sell	-11,812	Closed	-$27K	–	4108
2023 Q4	$27K	Buy	+11,812	New	+$25.7K	﹤0.01%	3901
2021 Q1	–	Sell	-1,070	Closed	-$28K	–	3171
2020 Q4	$28K	Buy	+1,070	New	+$27.1K	﹤0.01%	2832
2019 Q4	–	Sell	-1,971	Closed	-$49K	–	2505
2019 Q3	$49K	Buy	+1,971	New	+$54.1K	﹤0.01%	2243

Squarepoint's CKPT Position: Q2 2025 in Review

Squarepoint sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 471,385 shares — an estimated $1.9M sold.

Squarepoint first reported a position in CKPT in Q3 2019 and held it in 5 quarters. The position peaked at $1.9M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Squarepoint reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Squarepoint sold 471,385 Checkpoint Therapeutics shares in Q2 2025, an estimated $1.9M.
Squarepoint first reported a position in Checkpoint Therapeutics in Q3 2019 and held it in 5 quarters.
Squarepoint's Checkpoint Therapeutics position peaked at $1.9M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.